Joanna Peak, Partner with Boult Wade Tennant, to Speak at TKG's Warner-Lambert v. Actavis Webinar

Joanna Peak, Partner with Boult Wade Tennant, to Speak at The Knowledge Group's The Warner-Lambert v. Actavis at The Supreme Court

Online PR News – 28-June-2018 – 06/27/2018 - New York – The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Joanna Peak, Partner with Boult Wade Tennant, will speak at The Knowledge Group's webcast entitled: "The Warner-Lambert v. Actavis at The Supreme Court: Potential Implications on the Patent Infringement Landscape." This event is scheduled for July 26, 2018 from 10:00 am to 11:00 am ET.

For further details, please visit:

About Joanna Peak

Joanna, Partner, is a Chartered Patent Attorney and European Patent Attorney in the Biotechnology and Life Sciences Group.

Joanna has extensive experience of preparing and prosecuting patent applications before the UK and European Patent Offices. She regularly assists clients with managing global patent portfolios and providing commercial advice, including the preparation of freedom-to-operate opinions. She has also represented clients at oral proceedings before the European Patent Office at both first and second instance. Joanna works with a range of organisations from universities and SMEs through to multinational pharmaceutical companies.

Joanna has a PhD from the University of London. Her doctoral research, carried out at The Institute of Cancer Research, investigated the role of key molecules implicated in tumour invasion and metastasis.

Joanna also has an MA Cantab (Natural Sciences) and an MSci Biochem, both from the University of Cambridge.

About Boult Wade Tennant

Boult Wade Tennant is a specialist Patent and Trade Mark firm. We exist to help individuals and businesses protect, manage and enforce their intellectual property rights on a global scale.

Our aim is simple - we aim to work with our clients, not just for them. This means we place emphasis not only on the quality of our work but also on the quality of the service we provide. Our award winning approach is down-to-earth and jargon-free. Our attorneys are renowned for being committed to helping our clients succeed and for providing a service that is focussed and aligned with our clients' commercial objectives.


The ongoing patent infringement litigation, Warner-Lambert v. Actavis, deals with the plausibility and breach of Warner-Lambert's (Pfizer) second medical use patent for the use of blockbuster drug pregabalin, which the company markets under the name Lyrica®. The generic pregabalin product, Lecaent®, is currently being sold by Actavis. Recently, the UK Supreme Court heard the latest instalment of the continuing battle. Both the High Court and the Court of Appeal have ruled in favor of Actavis, however, the decision was appealed to the UK Supreme Court.

The consideration of plausibility by the UK Supreme Court is expected to have significant implications for pharmaceutical companies, especially for those who seek to protect new drug use through second medical use claims.

Join a panel of key thought leaders and professionals assembled by The Knowledge Group as they bring the audience to a road beyond the basics of bringing or defending against Patent Infringement claims in light of Warner-Lambert v. Actavis. They will also offer an in-depth analysis of the case's implications on the patent infringement landscape as well as on patent applications. Speakers will also provide the audience with practical strategies in bringing out the best in these lawsuits in a rapidly evolving legal climate.

Key topics include:

• Warner-Lambert v. Actavis - An Overview
• Latest Updates and Developments
• Implications on Patent Application Filings and the Patent Infringement Landscape
• Lessons Learned
• Litigation Strategies
• What's Next for the Pharma Industry?

About The Knowledge Group/The Knowledge Congress Live Webcast Series

The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: